These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15743541)

  • 1. JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Sugihara K
    BMC Cancer; 2005 Mar; 5():26. PubMed ID: 15743541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
    Kobayashi H; Gonda T; Uetake H; Higuchi T; Enomoto M; Sugihara K
    Int J Cancer; 2004 Dec; 112(6):920-6. PubMed ID: 15386343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.
    Yazawa K; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Asakage M; Sunami E; Kaisaki S; Hori N; Watanabe T; Takahashi K; Nagawa H
    Cancer Sci; 2005 Feb; 96(2):93-9. PubMed ID: 15723653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
    Nagahara T; Okano J; Murawaki Y
    Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
    Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
    Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.
    Sato N; Mizutani Y; Li YN; Fujiwara J; Ishida H; Toiyama D; Abe K; Hayashi I; Nakanishi H; Kawauchi A; Miki T
    Urol Int; 2010; 84(3):362-8. PubMed ID: 20389170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
    Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
    Nagahara T; Okano J; Fujise Y; Abe R; Murawaki Y
    Biomed Pharmacother; 2010 May; 64(5):319-26. PubMed ID: 20434301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
    Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
    Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
    Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
    Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G
    Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
    Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
    Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.